Assignment Module 3: Guidelines
(2023-2024)
1.3 Localised and locally advanced prostate cancer
The BPMN-file
Figure 1.3 Localised and locally advanced prostate cancer
1.3.1a Do you want your partner to have the results explained?
→ Yes or no
Motivation: The patient is asked to choose/decide whether the partner should also be involved,
so this is an inquiry.
1.3.1b Yes? Explain to people and their partner that radical treatment for prostate cancer will
result in an alteration of sexual experience, and may result in loss of sexual function.
Motivation: This is an action because it involves transfer of information to both the patient and
their partner regarding the potential impact of treatment on sexual function. It requires a verbal
explanation.
, 1.3.1c No? Explain to people that radical treatment for prostate cancer will result in an alteration
of sexual experience, and may result in loss of sexual function.
Motivation: Similar to the previous action, this involves transfer of information about the
potential effects of treatment, but in this case only to the patient.
1.3.2a Do you want your partner to have the risks explained?
→ Yes or no
Motivation: This is an enquiry because it seeks information from the patient about their
preference regarding involving their partner in the explanation of treatment risks.
1.3.2b Yes? Explain to people and their partner about the potential loss of ejaculation and
fertility associated with radical treatment for prostate cancer.
Motivation: This involves providing detailed information about specific risks to both the patient
and their partner, so this is an action.
1.3.2c No? Explain to people about the potential loss of ejaculation and fertility associated with
radical treatment for prostate cancer.
Motivation: Similar to the previous action, this involves providing information about risks, but
only to the patient.
1.3.2d Offer sperm storage.
Motivation: This is an action as it involves offering/providing a specific service (sperm storage)
due to the potential loss of fertility due to treatment.
1.3.3a Warn people undergoing radical treatment for prostate cancer of the likely effects of the
treatment on their urinary function.
Motivation: This is an action because it involves providing a warning about a potential side
effect of treatment.
1.3.4a Troublesome urinary symptoms?
→ Yes or No?
Motivation: This is an enquiry because it seeks information from the patient about their current
urinary symptoms to determine if further action is necessary.
1.3.4b Yes? Offer a urological assessment.
Motivation: This is an action because it involves providing a specific course of action (urological
assessment).
1.3.5a People with prostate cancer who are candidates for radical treatment should have the
opportunity to discuss the range of treatment modalities and their serious side effects in relation
to their treatment options with a specialist surgical oncologist and a specialist clinical oncologist.
Motivation: This is a plan as it outlines a sequence of actions aimed at facilitating discussions
between patients and specialists regarding treatment options and their associated risks.
(2023-2024)
1.3 Localised and locally advanced prostate cancer
The BPMN-file
Figure 1.3 Localised and locally advanced prostate cancer
1.3.1a Do you want your partner to have the results explained?
→ Yes or no
Motivation: The patient is asked to choose/decide whether the partner should also be involved,
so this is an inquiry.
1.3.1b Yes? Explain to people and their partner that radical treatment for prostate cancer will
result in an alteration of sexual experience, and may result in loss of sexual function.
Motivation: This is an action because it involves transfer of information to both the patient and
their partner regarding the potential impact of treatment on sexual function. It requires a verbal
explanation.
, 1.3.1c No? Explain to people that radical treatment for prostate cancer will result in an alteration
of sexual experience, and may result in loss of sexual function.
Motivation: Similar to the previous action, this involves transfer of information about the
potential effects of treatment, but in this case only to the patient.
1.3.2a Do you want your partner to have the risks explained?
→ Yes or no
Motivation: This is an enquiry because it seeks information from the patient about their
preference regarding involving their partner in the explanation of treatment risks.
1.3.2b Yes? Explain to people and their partner about the potential loss of ejaculation and
fertility associated with radical treatment for prostate cancer.
Motivation: This involves providing detailed information about specific risks to both the patient
and their partner, so this is an action.
1.3.2c No? Explain to people about the potential loss of ejaculation and fertility associated with
radical treatment for prostate cancer.
Motivation: Similar to the previous action, this involves providing information about risks, but
only to the patient.
1.3.2d Offer sperm storage.
Motivation: This is an action as it involves offering/providing a specific service (sperm storage)
due to the potential loss of fertility due to treatment.
1.3.3a Warn people undergoing radical treatment for prostate cancer of the likely effects of the
treatment on their urinary function.
Motivation: This is an action because it involves providing a warning about a potential side
effect of treatment.
1.3.4a Troublesome urinary symptoms?
→ Yes or No?
Motivation: This is an enquiry because it seeks information from the patient about their current
urinary symptoms to determine if further action is necessary.
1.3.4b Yes? Offer a urological assessment.
Motivation: This is an action because it involves providing a specific course of action (urological
assessment).
1.3.5a People with prostate cancer who are candidates for radical treatment should have the
opportunity to discuss the range of treatment modalities and their serious side effects in relation
to their treatment options with a specialist surgical oncologist and a specialist clinical oncologist.
Motivation: This is a plan as it outlines a sequence of actions aimed at facilitating discussions
between patients and specialists regarding treatment options and their associated risks.
